Hepatitis

Infectious Disease·MeSH: Hepatitis, Alcoholic

Prevalence

5000.0 / 100K

Incidence

500.0 / 100K/yr

166 drugs in development·73 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(27)
Phase 2(65)
DrugCompany
ab-729Arbutus Biopharma Corp (ABUS)
ADX-629Aldeyra Therapeutics, Inc. (ALDX)
ALG-000184Aligos Therapeutics, Inc. (ALGS)
aln-hsdREGENERON PHARMACEUTICALS, INC. (REGN)
ARC-520 InjectionARROWHEAD PHARMACEUTICALS, INC. (ARWR)
bemnifosbuvirAtea Pharmaceuticals, Inc. (AVIR)
BemnifosbuvirARROWHEAD PHARMACEUTICALS, INC. (ARWR)
bepirovirsenIONIS PHARMACEUTICALS INC (IONS)
BIO89-10089bio, Inc. (ETNB)
chadox1-hbvBarinthus Biotherapeutics plc. (BRNS)
chlorpheniramineARROWHEAD PHARMACEUTICALS, INC. (ARWR)
daplusiran/tomligisiranARROWHEAD PHARMACEUTICALS, INC. (ARWR)
efruxiferminAkero Therapeutics, Inc. (AKRO)
EFXAkero Therapeutics, Inc. (AKRO)
entecavirARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ervogastatMADRIGAL PHARMACEUTICALS, INC. (MDGL)
fxr314VivoSim Labs, INC. (VIVS)
hepatitis b vaccinePOINT Biopharma Global Inc. (PNT)
hh-003China Health Industries Holdings, Inc. (CHHE)
hm15211ANI PHARMACEUTICALS INC (ANIP)
hu6Corvus Pharmaceuticals, Inc. (CRVS)
hu6West Pharmaceutical Services Inc. (WST)
imdusiranArbutus Biopharma Corp (ABUS)
imdusiran (AB-729)Arbutus Biopharma Corp (ABUS)
inebilizumabAMGEN INC (AMGN)
int-787INTERCEPT PHARMACEUTICALS, INC. (ICPT)
larsucosterolDURECT CORP (DRRX)
mgl-3196MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MLR-1023Adhera Therapeutics, Inc. (ATRX)
mva-hbvBarinthus Biotherapeutics plc. (BRNS)
nasPOINT Biopharma Global Inc. (PNT)
ngm282NGM BIOPHARMACEUTICALS INC (NGM)
nnc0174 0833Novo Nordisk A/S (NVO)
nnc0194 0499Novo Nordisk A/S (NVO)
nucleoside analogsSPRING PHARMACEUTICAL GROUP, INC. (CYIG)
peg-ifnPOINT Biopharma Global Inc. (PNT)
peg-ifnαVir Biotechnology, Inc. (VIR)
Peg-IFNα-2aArbutus Biopharma Corp (ABUS)
pegylated interferon alpha 2aARROWHEAD PHARMACEUTICALS, INC. (ARWR)
pegylated interferon-alfa 2aVir Biotechnology, Inc. (VIR)
pevifoscorvirAligos Therapeutics, Inc. (ALGS)
PLN-1474PLIANT THERAPEUTICS, INC. (PLRX)
ptm cilo/firGILEAD SCIENCES, INC. (GILD)
ptm semaGILEAD SCIENCES, INC. (GILD)
Rencofilstat (formerly CRV431; CPI-431-32)Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)Hepion Pharmaceuticals, Inc. (CTRVP)
rg6346Dicerna Pharmaceuticals Inc (DRNA)
ruzasvirAtea Pharmaceuticals, Inc. (AVIR)
RuzasvirARROWHEAD PHARMACEUTICALS, INC. (ARWR)
seladelparCymaBay Therapeutics, Inc. (CBAY)
selgantolimodGILEAD SCIENCES, INC. (GILD)
SynthroidENANTA PHARMACEUTICALS INC (ENTA)
tafChina Health Industries Holdings, Inc. (CHHE)
tdfAligos Therapeutics, Inc. (ALGS)
tenofovir alafenamideGILEAD SCIENCES, INC. (GILD)
tenofovir disoproxilARROWHEAD PHARMACEUTICALS, INC. (ARWR)
TobevibartXencor Inc (XNCR)
tqa3334SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tvb-2640Sagimet Biosciences Inc. (SGMT)
vbi-2601VBI VACCINES INC/BC (VBIV)
vir-2218GILEAD SCIENCES, INC. (GILD)
vir-2218Vir Biotechnology, Inc. (VIR)
vir-3434Vir Biotechnology, Inc. (VIR)
VTP-300Barinthus Biotherapeutics plc. (BRNS)
zetomipzomibKezar Life Sciences, Inc. (KZR)
Phase 1(41)
DrugCompany
AB-101Arbutus Biopharma Corp (ABUS)
abi-4334ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-4334 (4334)ASSEMBLY BIOSCIENCES, INC. (ASMB)
abi-6250ASSEMBLY BIOSCIENCES, INC. (ASMB)
acetaminophenARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Acetaminophen 1000 mg/dARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Acetaminophen 4000 mg/dARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ACT500 tabletsCrinetics Pharmaceuticals, Inc. (CRNX)
ahb-137POINT Biopharma Global Inc. (PNT)
ahb-171POINT Biopharma Global Inc. (PNT)
ALG-001075Aligos Therapeutics, Inc. (ALGS)
ALG-125755Aligos Therapeutics, Inc. (ALGS)
aln-cidebREGENERON PHARMACEUTICALS, INC. (REGN)
antihistamineARROWHEAD PHARMACEUTICALS, INC. (ARWR)
aramchol free acidGalmed Pharmaceuticals Ltd. (GLMD)
arc-520ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARC-521 InjectionARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-HBVARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-HSD InjectionARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-PNPLA3ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
cotadutideASTRAZENECA PLC (AZN)
diphenhydramineARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Duloxetine- AcetaminophenARROWHEAD PHARMACEUTICALS, INC. (ARWR)
EDP-514ENANTA PHARMACEUTICALS INC (ENTA)
hec169584SUNSHINE BIOPHARMA INC. (SBFM)
IMC-I109VImmunocore Holdings plc (IMCR)
JNJ-56136379ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
MGL-2086MADRIGAL PHARMACEUTICALS, INC. (MDGL)
miricorilantCORCEPT THERAPEUTICS INC (CORT)
nucleoside analoguePOINT Biopharma Global Inc. (PNT)
Nucleoside AnalogueArbutus Biopharma Corp (ABUS)
ontamalimabTAKEDA PHARMACEUTICAL CO LTD (TKPHF)
ontamalimabTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
pbgene-hbvPRECISION BIOSCIENCES INC (DTIL)
pbgene-liverPRECISION BIOSCIENCES INC (DTIL)
peripheral ivCurative Biotechnology Inc (CUBT)
Pregabalin- AcetaminophenARROWHEAD PHARMACEUTICALS, INC. (ARWR)
szn-043Surrozen Inc. (SRZN)
tenofovirARROWHEAD PHARMACEUTICALS, INC. (ARWR)
tern-501Terns Pharmaceuticals, Inc. (TERN)
vay736Novartis AG (NVS)

Compare drugs

Frequently asked questions

How many drugs are in development for Hepatitis?

BioSniper tracks 166 drugs in development for Hepatitis across 73 companies.

How many clinical trials target Hepatitis?

There are 1 clinical trial targeting Hepatitis tracked by BioSniper.

What is the prevalence of Hepatitis?

The estimated prevalence of Hepatitis is approximately 5000.0 per 100,000 population.

Deep-dive into Hepatitis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis